| | Mental Health | Schizophrenia
Schizophrenia and DSM-5: Diagnostic Criteria, Classification, and Updates
Schizophrenia in DSM-5
Schizophrenia is a chronic psychotic disorder classified under Schizophrenia Spectrum and Other Psychotic Disorders in DSM-5 (2013). The multiaxial system (Axis I–V) was eliminated in DSM-5. Diagnoses are now listed non-axially with specifiers.
Diagnostic Criteria (Criterion A: ≥2 for ≥1 month, at least one must be 1–3)
- Delusions
- Hallucinations
- Disorganized speech
- Grossly disorganized or catatonic behavior
- Negative symptoms (diminished emotional expression, avolition)
Criterion B: Social/occupational dysfunction for ≥6 months (includes prodromal/residual periods).
Criterion C: Exclude schizoaffective disorder, mood disorder with psychotic features, substance/medical causes.
Key DSM-5 Changes from DSM-IV
- No subtypes (paranoid, disorganized, catatonic, undifferentiated, residual)—poor validity and reliability.
- Catatonia: separate specifier (can apply to depressive, bipolar, medical conditions).
- Dimensional assessment: severity ratings for 8 symptom domains (hallucinations, delusions, disorganized speech, abnormal psychomotor behavior, negative symptoms, impaired cognition, depression, mania).
- Schizotypal personality disorder moved to this chapter (spectrum concept).
Related Diagnoses in the Chapter
- Schizotypal personality disorder
- Delusional disorder
- Brief psychotic disorder
- Schizophreniform disorder (1–6 months)
- Schizoaffective disorder (mood episodes concurrent + psychotic symptoms without mood symptoms)
- Substance/medication-induced psychotic disorder
- Psychotic disorder due to another medical condition
- Catatonia (associated with...)
Clinical Assessment
- Structured interviews: SCID-5, CAARMS (at-risk), PANSS (severity).
- Rule out: medical (encephalitis, autoimmune, metabolic, neoplastic), substance, mood disorders.
- Neuroimaging (MRI) if atypical onset, focal signs, late onset.
- Labs: CBC, CMP, TSH, B12/folate, RPR, HIV, toxicology, copper/ceruloplasmin (Wilson's), ANA.
Treatment Overview
- Antipsychotics: Second-generation (risperidone, olanzapine, quetiapine, aripiprazole, lurasidone, cariprazine) first-line; clozapine for treatment-resistant (≥2 failed trials).
- Psychosocial: CBTp, family psychoeducation, supported employment/education (IPS), ACT, cognitive remediation, social skills training.
- Early intervention (CSC): Coordinated specialty care for first-episode psychosis → better outcomes.
- Long-acting injectables (LAIs): Improve adherence, reduce relapse.
Prognosis
Heterogeneous. ~20% recover well; ~40% recurrent episodes with functional impairment; ~40% chronic disability. Early treatment, adherence, family support, and addressing social determinants improve trajectory.
Schizophrenia - Related Articles
- Therapy for Schizophrenia: Types, Benefits, and Complementary Treatments
- Psychiatrist: Role, Training, Conditions Treated, and How to Choose One
- Cats and Schizophrenia: No Causal Link Established
- Understanding Schizophrenia in Teenage Boys: Symptoms & Early Signs
- Schizophrenia Therapy Options: Evidence-Based Psychotherapies and Access
- Understanding Prodromal Symptoms of Schizophrenia: Early Warning Signs
- Clarisse in Fahrenheit 451: The Psychiatrist's Interest in Her Uniqueness
